DANIEL J BOOSER to Protein Kinase Inhibitors
This is a "connection" page, showing publications DANIEL J BOOSER has written about Protein Kinase Inhibitors.
Connection Strength
0.007
-
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations. Ann Oncol. 2008 Oct; 19(10):1713-9.
Score: 0.007
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.